WHO ICTRP trial
Efficacy and mechanism of MEBO in repairing type 2 diabetic foot ulcer
ITMCTR2025001353 · International Traditional Medicine Clinical Trial Registry (ITMCTR) · Recruiting
Key facts
| Trial ID | ITMCTR2025001353 |
|---|---|
| Public title | Efficacy and mechanism of MEBO in repairing type 2 diabetic foot ulcer |
| Scientific title | Efficacy and mechanism of MEBO in repairing type 2 diabetic foot ulcer |
| Primary sponsor | Yantai Yuhuangding Hospital |
| Registry | International Traditional Medicine Clinical Trial Registry (ITMCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | Pilot clinical trial |
| Countries | China |
| Conditions | Type 2 diabetic foot ulcer |
| Interventions | Experimental group:Routine debridement and dressing change+MEBO;Control group:Routine debridement and dressing change |
| Registration date | Jul 9, 2025 |
| Target size | Experimental group:30;Control group:30 |
| Registry page | itmctr.ccebtcm.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: